Presently, it stands as the largest observational study investigating the potential link between DPP-4 inhibitors and acute pancreatitis, uniquely concentrating on individuals with T2D, particularly those with a history of prior hospitalization for acute pancreatitis. The gene discussed is DPP4; the disease is type 2 diabetes mellitus.